Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis

Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis

US Patent 11963984 · Granted Apr 23, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating septic shock2025
Methods and kits for predicting the risk of having a cardiovascular disease or e2021
Methods and kits for predicting the risk of having a cardiovascular disease or e2021
Therapeutic TREM-1 peptides2020
Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof2017
Inhibiting peptides derived from triggering receptor expressed on myeloid cells-2017
Inhibiting peptides derived from triggering receptor expressed on myeloid cells-2017
Therapeutic TREM-1 peptides2016
Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof2016
Method of diagnosing infectious disease by measuring the level of soluble TREM-12011
Therapeutic peptides and method2011